Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.  Chen PH, Yenokyan K, Fojo AT, Hutton HE, Lesko CR, McCaul ME, Yang C, Cachay ER, Crane HM, Jacobson…

EASL recommendations on treatment of hepatitis C: Final update of the series Pawlotsky, Jean-MichelNegro, FrancescoAghemo, Alessio et al. Journal of Hepatology, Volume 73, Issue 5, 1170 - 1218  https://www.journal-of-hepatology.eu/article/S0…

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates.  Lens S, Miralpeix A, Gálvez M, Martró E, González N, Rodríguez-Tajes S, Mariño Z, Saludes V, Reyes-Urueña J, Majó X, Colom…

Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals. Ogawa E, Nomura H, Nakamuta M, Furusyo N, Kajiwara E, Dohmen K, Kawano A, Ooho A, Azuma K, Takahashi K, Satoh T, Ko…

HIV? Hepatitis? Das CHECK ich!  Modellprojekt zu Beratungen und Tests für Menschen, die Drogen gebrauchen, durchgeführt in niedrigschwelligen Einrichtungen der Drogenhilfe. Abschlussbericht zu den Ergebnissen der Begleitevaluation Herausgebe…

Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020.  Thompson WW, Symum H, Sandul A, et al.  MMWR Morb Mortal Wkly Rep 2022;71:1011-1017. doi.org/10.15585/mmwr.mm7132e1 https://www.cdc.gov/mmwr/volum…